Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4049 Target Snapshot

Aldo-keto reductase family 1 member A1 · SINGLE PROTEIN · Sus scrofa

17Compounds
10Assays
3Approved Drugs
18.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P50578. Use UniProt P50578 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P50578 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aldo-keto reductase family 1 member A1 as ChEMBL target CHEMBL4049, mapped to UniProt P50578. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aldo-keto reductase family 1 member A1
SINGLE PROTEIN · Sus scrofa
As of 2026-09-13
ChEMBL target ID
CHEMBL4049
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P50578
Aldo-keto reductase family 1 member A1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aldo-keto reductase family 1 member A1 is the right protein anchor across sources, using UniProt P50578 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAldo-keto reductase family 1 member A1
UniProt AccessionP50578
Component TypeProtein
Sequence Length325 aa

Aldo-keto reductase family 1 member A1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aldo-keto reductase family 1 member A1, mapped to UniProt P50578. Sequence length is 325 aa.

Mapped IDP50578
Review nameAldo-keto reductase family 1 member A1
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC5018.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL269550 9.32 IC50 0.48 Preclinical
CHEMBL7480 7.57 IC50 27.0 Preclinical
CHEMBL273910 7.4 IC50 40.0 Clinical
CHEMBL436 6.27 IC50 540.0 Approved
CHEMBL56337 5.82 IC50 1500.0 Approved
CHEMBL266497 5.72 IC50 1900.0 Clinical
CHEMBL7679 5.7 IC50 2000.0 Clinical
CHEMBL84446 5.6 IC50 2500.0 Clinical
CHEMBL396176 5.27 IC50 5400.0 Preclinical
CHEMBL449129 4.95 IC50 11300.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
5
5.5
1
6.0
0
6.5
1
7.0
1
7.5
0
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TOLRESTAT
CHEMBL436
Approved 1989
Assay Landscape

Assay Landscape

10
Total Assays
15
Tested Compounds
1
Assay Types
Binding — 10 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 15 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine